A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)

NCT01156961 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Absence of patient's recruitment in the study due to administrative reasons

Conditions

Interventions

Sponsor

Hoffmann-La Roche